ClinicalTrials.govpublic full text
Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
recessive dystrophic epidermolysis bullosa, epidermolysis bullosa, epidermolysis bullosa dystrophica, skin abnormalities, congenital abnormalities, skin diseases, genetic, somatic cell therapy, mesenchymal stem cells, abcb5, allogeneic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 841708
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.